Cardiomyocyte proliferation is suppressed by ARID1A-mediated YAP inhibition during cardiac maturation

Cornelis J Boogerd1, Ilaria Perini2, Eirini Kyriakopoulou2

  • 1Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences (KNAW) and University Medical Center Utrecht, Utrecht, Netherlands. K.boogerd@hubrecht.eu.

Nature Communications
|August 5, 2023
PubMed

Insights

Adult cardiomyocytes cannot regenerate due to a lack of proliferation. Arid1a, a chromatin remodeler, suppresses proliferation and promotes maturation, offering new avenues for cardiac repair research.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Epigenetics

Background:

  • Adult cardiomyocyte proliferation is limited, hindering cardiac regeneration after injury.
  • Understanding the switch to a non-regenerative state is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of Arid1a in regulating postnatal cardiomyocyte proliferation and maturation.
  • To elucidate the molecular mechanisms by which Arid1a controls cardiomyocyte cell cycle exit.

Main Methods:

  • Genome-wide transcriptome and epigenome analyses were performed.
  • Arid1a's interaction with YAP/TAZ and TEAD was assessed.
  • Arid1a's role was evaluated in a mouse model of ischemic heart disease.

Main Results:

  • Arid1a, a SWI/SNF complex subunit, suppresses cardiomyocyte proliferation and promotes maturation.
  • Arid1a facilitates DNA access for transcription factors driving cardiomyocyte maturation.
  • Arid1a directly inhibits YAP/TAZ, sequestering them from TEAD.
  • Inactivation of Arid1a post-ischemic injury enhances border zone cardiomyocyte proliferation.

Conclusions:

  • Arid1a is a key regulator of cardiomyocyte maturation and a critical suppressor of proliferation.
  • Targeting Arid1a may offer a novel strategy for promoting cardiac regeneration.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K